Q1 Earnings Forecast for USNA Issued By DA Davidson

USANA Health Sciences, Inc. (NYSE:USNA) – Stock analysts at DA Davidson issued their Q1 2025 earnings per share estimates for USANA Health Sciences in a research note issued on Tuesday, February 25th. DA Davidson analyst C. Xue expects that the company will post earnings of $0.83 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $36.00 target price on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share.

A number of other brokerages have also commented on USNA. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

USANA Health Sciences Stock Down 14.0 %

Shares of NYSE USNA opened at $28.57 on Wednesday. The business’s 50 day moving average price is $33.50 and its 200 day moving average price is $36.56. The firm has a market cap of $544.54 million, a P/E ratio of 10.10, a P/E/G ratio of 0.93 and a beta of 0.87. USANA Health Sciences has a 52 week low of $27.71 and a 52 week high of $50.32.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. The firm had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Barclays PLC lifted its holdings in USANA Health Sciences by 111.9% in the third quarter. Barclays PLC now owns 27,737 shares of the company’s stock valued at $1,052,000 after acquiring an additional 14,647 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in USANA Health Sciences by 14,068.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after acquiring an additional 38,547 shares during the period. Assenagon Asset Management S.A. lifted its holdings in USANA Health Sciences by 13.5% in the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after acquiring an additional 14,756 shares during the period. Geode Capital Management LLC lifted its holdings in USANA Health Sciences by 4.5% in the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after acquiring an additional 12,898 shares during the period. Finally, State Street Corp lifted its holdings in USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock valued at $16,501,000 after acquiring an additional 2,782 shares during the period. 54.25% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.